Tesofensine
$200.00
Tesofensine is a synthetic small-molecule compound classified in laboratory research as a triple monoamine reuptake inhibitor, influencing serotonin, norepinephrine, and dopamine transporter activity. In controlled experimental models, it is studied for its modulation of central neurotransmitter dynamics and downstream neuroendocrine signaling pathways.
Preclinical investigations—including in vitro systems and animal models—commonly examine presynaptic transporter inhibition, hypothalamic signaling regulation, and associated changes in energy balance pathways under defined laboratory conditions. Research applications frequently focus on neurotransmitter turnover, receptor-mediated signaling, and central mechanisms involved in metabolic and appetite-related pathway modeling. These systems provide structured environments for evaluating monoaminergic signaling and hypothalamic control mechanisms without implying human application.
Quality & Research Integrity
All Hanobi® research compounds are manufactured under strict quality control standards within our U.S.-based operations. Materials are sourced from independently vetted, accredited suppliers and undergo analytical verification to confirm identity and purity prior to release. Our processes are designed to ensure consistency, traceability, and full regulatory compliance for research-use materials.
Capsule Disclaimer
Capsules are supplied solely as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any manner.
For Research Use Only (RUO)
Not for use in humans or animals. Not for diagnostic or therapeutic purposes.
References
Appel L et al., Neuropsychopharmacology, 2011;36(3):654–662
Astrup A et al., The Lancet, 2008;372(9653):1906–1913
Eisenstein SA et al., Journal of Pharmacology and Experimental Therapeutics, 2015;352(1):129–138